Komori
Biprogy (8056) · InitiativeFirst stated

Addressing ELSI through AI ethics guidelines and ethics reviews for life sciences research

First written in FY2022. . Latest entry: FY2022.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
ELSI Responses through Ethics Reviews of AI and Life Sciences ResearchA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022First statedAnnual report

    「We are addressing the ethical, legal and social issues arising from the rapid advancement of science and technology (ELSI: Ethical, Legal and Social Issues) by promoting responsible research and development with the Life Sciences Research Ethics Review Committee, which includes external experts, serving as an advisory body, and by formulating and operating AI ethics guidelines to recognize and appropriately address the positive and negative effects of AI on people and society.」

    The formulation and operation of AI ethics guidelines and a review framework including external experts were identified for the first time as themes covering the social impact of AI and the ethical aspects of life sciences research.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Biprogy's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.